454 related articles for article (PubMed ID: 21270616)
1. Oncologic results and surgical morbidity of laparoscopic nerve-sparing radical hysterectomy in the treatment of FIGO stage IB cervical cancer: long-term follow-up.
Park NY; Chong GO; Hong DG; Cho YL; Park IS; Lee YS
Int J Gynecol Cancer; 2011 Feb; 21(2):355-62. PubMed ID: 21270616
[TBL] [Abstract][Full Text] [Related]
2. Laparoscopic nerve-sparing radical hysterectomy without uterine manipulator for cervical cancer stage IB: description of the technique, our experience and results after the era of LACC trial.
Kavallaris A; Chalvatzas N; Gkoutzioulis A; Zygouris D
Arch Gynecol Obstet; 2021 Apr; 303(4):1039-1047. PubMed ID: 33068159
[TBL] [Abstract][Full Text] [Related]
3. Can laparoscopic radical hysterectomy be a standard surgical modality in stage IA2-IIA cervical cancer?
Hong JH; Choi JS; Lee JH; Eom JM; Ko JH; Bae JW; Park SH
Gynecol Oncol; 2012 Oct; 127(1):102-6. PubMed ID: 22683586
[TBL] [Abstract][Full Text] [Related]
4. [Laparoscopic anatomical nerve sparing radical hysterectomy for cervical cancer: a clinical analysis of 37 cases].
Chen Y; Li Y; Xu HC; Li JN; Li YY; Liang ZQ
Zhonghua Fu Chan Ke Za Zhi; 2009 May; 44(5):359-63. PubMed ID: 19573312
[TBL] [Abstract][Full Text] [Related]
5. A comparison of stages IB1 and IB2 cervical cancers treated with radical hysterectomy. Is size the real difference?
Rutledge TL; Kamelle SA; Tillmanns TD; Gould NS; Wright JD; Cohn DE; Herzog TJ; Rader JS; Gold MA; Johnson GA; Walker JL; Mannel RS; McMeekin DS
Gynecol Oncol; 2004 Oct; 95(1):70-6. PubMed ID: 15385112
[TBL] [Abstract][Full Text] [Related]
6. Comparison of survival and adverse events between women with stage IB1 and stage IB2 cervical cancer treated by laparoscopic radical vaginal hysterectomy.
Hong JH; Choi JS; Lee JH; Son CE; Jeon SW; Bae JW; Eom JM
Ann Surg Oncol; 2012 Feb; 19(2):605-11. PubMed ID: 21769469
[TBL] [Abstract][Full Text] [Related]
7. Cavitron Ultrasonic Surgical Aspirator in Laparoscopic Nerve-Sparing Radical Hysterectomy: A Pilot Study.
Hao M; Wang Z; Wei F; Wang J; Wang W; Ping Y
Int J Gynecol Cancer; 2016 Mar; 26(3):594-9. PubMed ID: 26807637
[TBL] [Abstract][Full Text] [Related]
8. [Feasibility of unilateral or bilateral nerve-sparing radical hysterectomy in patients with cervical cancer and evaluation of the post-surgery recovery of the bladder and rectal function].
Zhu T; Yu AJ; Shou HF; Chen X; Zhu JQ; Yang ZY; Zhang P; Gao YL
Zhonghua Zhong Liu Za Zhi; 2011 Jan; 33(1):53-7. PubMed ID: 21575466
[TBL] [Abstract][Full Text] [Related]
9. Open versus laparoscopic pelvic lymph node dissection in early stage cervical cancer: no difference in surgical or disease outcome.
van de Lande J; von Mensdorff-Pouilly S; Lettinga RG; Piek JM; Verheijen RH
Int J Gynecol Cancer; 2012 Jan; 22(1):107-14. PubMed ID: 21857347
[TBL] [Abstract][Full Text] [Related]
10. Comparison of laparoscopic versus abdominal radical hysterectomy for FIGO stage IB and IIA cervical cancer with tumor diameter of 3 cm or greater.
Kong TW; Chang SJ; Lee J; Paek J; Ryu HS
Int J Gynecol Cancer; 2014 Feb; 24(2):280-8. PubMed ID: 24407571
[TBL] [Abstract][Full Text] [Related]
11. Impact of laparoscopic radical hysterectomy on survival outcome in patients with FIGO stage IB cervical cancer: A matching study of two institutional hospitals in Korea.
Kim SI; Lee M; Lee S; Suh DH; Kim HS; Kim K; Chung HH; No JH; Kim JW; Park NH; Song YS; Kim YB
Gynecol Oncol; 2019 Oct; 155(1):75-82. PubMed ID: 31383569
[TBL] [Abstract][Full Text] [Related]
12. Comparison of laparoscopic and open radical hysterectomy in cervical cancer patients with tumor size ≤2 cm.
Chen X; Zhao N; Ye P; Chen J; Nan X; Zhao H; Zhou K; Zhang Y; Xue J; Zhou H; Shang H; Zhu H; Leanne VM; Yan X
Int J Gynecol Cancer; 2020 May; 30(5):564-571. PubMed ID: 32276941
[TBL] [Abstract][Full Text] [Related]
13. Class III NSRH: oncological outcome in 170 cervical cancer patients.
Ditto A; Martinelli F; Hanozet F; Reato C; Solima E; Zanaboni F; Grijuela B; Carcangiu M; Haeusler E; Raspagliesi F
Gynecol Oncol; 2010 Nov; 119(2):192-7. PubMed ID: 20719370
[TBL] [Abstract][Full Text] [Related]
14. The upper limit of optimal tumor size in patients with FIGO 2018 stage IB2 cervical cancer undergoing radical hysterectomy.
Hwang WY; Kim JH; Suh DH; Kim K; No JH; Kim YB
Int J Gynecol Cancer; 2020 Jul; 30(7):975-980. PubMed ID: 32467336
[TBL] [Abstract][Full Text] [Related]
15. Laparoscopic radical hysterectomy and pelvic lymphadenectomy can be routinely used for treatment of early-stage cervical cancer: a single-institute experience with 404 patients.
Yang L; Cai J; Dong W; Shen Y; Xiong Z; Wang H; Min J; Li G; Wang Z
J Minim Invasive Gynecol; 2015 Feb; 22(2):199-204. PubMed ID: 25281840
[TBL] [Abstract][Full Text] [Related]
16. A multi-institutional experience with robotic-assisted radical hysterectomy for early stage cervical cancer.
Lowe MP; Chamberlain DH; Kamelle SA; Johnson PR; Tillmanns TD
Gynecol Oncol; 2009 May; 113(2):191-4. PubMed ID: 19249082
[TBL] [Abstract][Full Text] [Related]
17. Robotics versus laparoscopic radical hysterectomy with lymphadenectomy in patients with early cervical cancer: a multicenter study.
Tinelli R; Malzoni M; Cosentino F; Perone C; Fusco A; Cicinelli E; Nezhat F
Ann Surg Oncol; 2011 Sep; 18(9):2622-8. PubMed ID: 21394663
[TBL] [Abstract][Full Text] [Related]
18. Radical hysterectomy for stage IB1 vs IB2 carcinoma of the cervix: does the new staging system predict morbidity and survival?
Finan MA; DeCesare S; Fiorica JV; Chambers R; Hoffman MS; Kline RC; Roberts WS; Cavanagh D
Gynecol Oncol; 1996 Aug; 62(2):139-47. PubMed ID: 8751541
[TBL] [Abstract][Full Text] [Related]
19. Class III nerve-sparing radical hysterectomy versus standard class III radical hysterectomy: an observational study.
Ditto A; Martinelli F; Mattana F; Reato C; Solima E; Carcangiu M; Haeusler E; Mariani L; Raspagliesi F
Ann Surg Oncol; 2011 Nov; 18(12):3469-78. PubMed ID: 21556949
[TBL] [Abstract][Full Text] [Related]
20. Self-Reported Long-Term Autonomic Function After Laparoscopic Total Mesometrial Resection for Early-Stage Cervical Cancer: A Multicentric Study.
Lucidi A; Windemut S; Petrillo M; Dessole M; Sozzi G; Vercellino GF; Baessler K; Vizzielli G; Sehouli J; Scambia G; Chiantera V
Int J Gynecol Cancer; 2017 Sep; 27(7):1501-1507. PubMed ID: 28708791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
